1. Home
  2. RVP vs PLUR Comparison

RVP vs PLUR Comparison

Compare RVP & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Retractable Technologies Inc.

RVP

Retractable Technologies Inc.

N/A

Current Price

$0.69

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$0.97

Market Cap

18.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVP
PLUR
Founded
1994
2001
Country
United States
Israel
Employees
201
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
18.5M
IPO Year
2000
2001

Fundamental Metrics

Financial Performance
Metric
RVP
PLUR
Price
$0.69
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $12.00
AVG Volume (30 Days)
13.3K
★ 16.6K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.46
EPS
★ N/A
N/A
Revenue
★ $38,266,211.00
$1,016,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 15.78
N/A
52 Week Low
$0.60
$0.98
52 Week High
$1.14
$4.87

Technical Indicators

Market Signals
Indicator
RVP
PLUR
Relative Strength Index (RSI) 46.98 29.10
Support Level $0.66 N/A
Resistance Level $0.74 $1.85
Average True Range (ATR) 0.02 0.13
MACD -0.00 -0.00
Stochastic Oscillator 27.82 9.76

Price Performance

Historical Comparison
RVP
PLUR

About RVP Retractable Technologies Inc.

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: